Biosimilars in the management of neutropenia: focus on filgrastim

Overview of attention for article published in Biologics: Targets & Therapy, February 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 926 followers.

RT @cesaro_simone: Biosimilars in the management of neutropenia: focus on filgrastim. - PubMed - NCBI https://t.co/mkai5Y6LeR

Biosimilars in the management of neutropenia: focus on filgrastim. - PubMed - NCBI https://t.co/mkai5Y6LeR

BIOSIMILARS in the management of neutropenia focus on filgrastim Authors: Caselli D, Cesaro S, Aricò M https://t.co/5qG7xnKFbu

Biosimilars in the management of neutropenia: focus on filgrastim - Dove Medical Press https://t.co/BvHwE8OlsY #biosimilars